155877-83-1
Chemical Structure
LE135
- CAS No.: 155877-83-1
- Formula:C29H30N2O2
- Molecular Weight:438.56
IUPAC Name: 4-(5,7,7,10,10-pentamethyl-7,8,9,10-tetrahydro-5H-benzo[e]naphtho[2,3-b][1,4]diazepin-13-yl)benzoic acid
InChIKey: YZZAIQOVMHVWBS-UHFFFAOYSA-N
SMILES: O=C(O)C1=CC=C(C2=NC3=CC4=C(C(C)(C)CCC4(C)C)C=C3N(C)C5=CC=CC=C52)C=C1
Biological Activity: LE135 is a potent RAR antagonist that binds selectively to RARα (Ki of 1.4 μM) and RARβ (Ki of 220 nM), and has a higher affinity to RARβ. LE135 is highly selective over RARγ, RXRα, RXRβ and RXRγ. LE135 is also a potent TRPV1 and TRPA1 receptors activator with EC50s of 2.5 μM and 20 μM, respectively[1][2].
| Cat. No. | 상품명 | Purity | 제품 설명 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
LE135 | 98.68% | LE135 is a potent RAR antagonist that binds selectively to RARα (Ki of 1.4 μM) and RARβ (Ki of 220 nM), and has a higher affinity to RARβ. LE135 is highly selective over RARγ, RXRα, RXRβ and RXRγ. LE135 is also a potent TRPV1 and TRPA1 receptors activator with EC50s of 2.5 μM and 20 μM, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.87
HY-120875HX600 -
Similarity Score 0.82
HY-117545LE-540 -
Similarity Score 0.76
HY-108521RHX531 (Standard) -
Similarity Score 0.69
HY-108520HX630 -
Similarity Score 0.55
HY-173159BMS-185354 -
Similarity Score 0.53
HY-182728CD564 -
Similarity Score 0.52
HY-14652RTamibarotene (Standard) -
Similarity Score 0.52
HY-108530RMM11253 (Standard) -
Similarity Score 0.52
HY-104070LG-100064 -
Explore the MedChemAI to find more analogs
References
- [1]. H Umemiya, et al. Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers. J Med Chem. 1997 Dec 19;40(26):4222-34. [Content Brief]
- [2]. Shijin Yin, et al. LE135, a retinoid acid receptor antagonist, produces pain through direct activation of TRP channels. Br J Pharmacol. 2014 Mar;171(6):1510-20. [Content Brief]
